
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.11 | 0.82 | 0.71 |
Shares | 3.29 | 3.29 | 0.00 |
Bonds | 93.79 | 93.79 | 0.00 |
Convertible | 1.12 | 1.12 | 0.00 |
Preferred | 1.66 | 1.66 | 0.00 |
Other | 0.03 | 0.03 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.27 | 27.38 |
Price to Book | 1.36 | 1.90 |
Price to Sales | 1.24 | 1.44 |
Price to Cash Flow | 6.33 | 7.06 |
Dividend Yield | 0.50 | 3.49 |
5 Years Earnings Growth | 14.73 | 12.72 |
Name | Net % | Category Average |
---|---|---|
Corporate | 95.28 | 85.09 |
Cash | 0.11 | 5.83 |
Securitized | 0.79 | 4.50 |
Government | 0.50 | 4.35 |
Number of long holdings: 863
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Fidelity Private Cr Co (Unit) | - | 1.49 | - | - | |
Mesquite Engy | - | 0.94 | - | - | |
EchoStar Corp. 10.75% | - | 0.88 | - | - | |
Artera Services LLC 8.5% | - | 0.55 | - | - | |
United States Treasury Notes 4.125% | - | 0.50 | - | - | |
Alliant Holdings Intermediate LLC/Alliant Holdings Co-Issuer Inc 6.75% | - | 0.50 | - | - | |
TransDigm, Inc. 6.375% | - | 0.50 | - | - | |
Medline Borrower LP 3.875% | - | 0.47 | - | - | |
Community Health Systems Incorporated 5.25% | - | 0.46 | - | - | |
Altice France S.A 5.125% | - | 0.46 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
US31617H1023 | 373.47B | 1.67 | 4.22 | 1.67 | ||
US3160671075 | 229.4B | 1.69 | 4.25 | 1.70 | ||
US31617H8051 | 119.89B | 1.74 | 4.46 | 1.92 | ||
Fidelity US Bond Index Instl Prem | 62.2B | 2.39 | 1.47 | 1.47 | ||
Strategic Advisers Core Income | 40.35B | 2.82 | 1.95 | 2.03 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review